Heart Failure
📧 Sign up to get email alerts when something new happens for Heart Failure.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2012-04-27FDA Approved: ATACAND — Supplemental Application (ANI Pharmaceuticals, Inc.)
FDA approved ANI Pharmaceuticals' supplemental application for ATACAND (candesartan cilexetil). This action updates the drug's labeling as p…
-
FDA approval · 2012-04-27FDA Approved: DIGOXIN — Supplemental Application (Sandoz Inc)
FDA approved a supplemental application for Digoxin submitted by Sandoz Inc.
-
CLINICAL_TRIALS trial_result · 2012-04-27Clinical Trial Update: The Clinical Study of the Efficacy and Safety of L-Carnitine Injection in Treatment of Heart Failure [Phase 2, Phase 3]
A completed Phase 2/3 clinical trial evaluating the efficacy and safety of L-Carnitine Injection for heart failure.
-
CLINICAL_TRIALS trial_result · 2012-04-17Clinical Trial Update: Feasibility Study of an Integrated Diagnostic System to Manage Heart Failure [NA]
A completed feasibility trial evaluating an integrated diagnostic system designed to help manage heart failure.
-
CLINICAL_TRIALS trial_result · 2012-04-10Clinical Trial Update: Association Between Genetic Polymorphism of Beta-adrenergic Receptor and Effects of Bisoprolol in Korean Heart Failure Patients. [Phase 4]
A Phase 4 clinical trial in Korean patients with chronic heart failure examined whether beta-adrenergic receptor genetic polymorphisms influ…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2012-04-04Clinical Trial Update: Sugammadex and Heart Failure [Phase 3]
Phase 3 trial evaluating sugammadex for patients with heart failure undergoing surgery has completed, reporting results related to reversal …
-
CLINICAL_TRIALS withdrawal · 2012-04-02Clinical Trial Update: Study of Percutaneous Renal Artery Intervention for Patient With Heart Failure [NA]
A clinical trial evaluating percutaneous renal artery intervention for patients with heart failure has been withdrawn.
-
FDA approval · 2012-03-29FDA Approved: ZESTRIL — Supplemental Application (Upsher-Smith Laboratories, LLC)
FDA approved a supplemental application for Zestril (lisinopril) submitted by Upsher-Smith Laboratories.
-
FDA approval · 2012-03-27FDA Approved: LASIX — Supplemental Application (Validus Pharmaceuticals LLC)
FDA approved a supplemental application for LASIX (furosemide) submitted by Validus Pharmaceuticals LLC.
-
CLINICAL_TRIALS trial_result · 2012-03-20Clinical Trial Update: Use of Defibrillator Information in the Emergency Department
A completed clinical trial from Ohio State University evaluating how defibrillator information is used in the emergency department for patie…
-
CLINICAL_TRIALS trial_result · 2012-03-20Clinical Trial Update: Effect of Quality Improvement Tools in Congestive Heart Failure (CHF) [NA]
Clinical trial update on the effect of quality improvement tools in congestive heart failure shows the study status as completed. The update…
-
CLINICAL_TRIALS trial_result · 2012-03-19Clinical Trial Update: Effect Of GW501516X On How The Heart Obtains And Uses Energy
This update reports termination of a GlaxoSmithKline trial evaluating GW501516 (Cardarine) and its effects on heart energy metabolism in dys…
-
CLINICAL_TRIALS research · 2012-03-07Clinical Trial Update: A Critical Pathway for Implantable Cardioverter-Defibrillators in Patients With Ischemic Cardiomyopathy [NA]
Clinical trial update exploring implantable cardioverter-defibrillators in patients with ischemic cardiomyopathy, sponsored by the Universit…
-
CLINICAL_TRIALS research · 2012-03-07Clinical Trial Update: Assessment of Exercise Intensity in Cardiac Rehabilitation Programmes for Patients With Chronic Heart Failure
A clinical trial update on assessing exercise intensity within cardiac rehabilitation programs for patients with heart failure, with the cur…
-
CLINICAL_TRIALS trial_result · 2012-03-06Clinical Trial Update: Assess Safety and Probable Benefit of the EXCOR® Pediatric Ventricular Assist Device Under a Continued Access Protocol
This clinical trial update describes the safety and probable benefit evaluation of the EXCOR pediatric ventricular assist device under a con…
-
FDA approval · 2012-03-05FDA Approved: DOBUTAMINE HYDROCHLORIDE IN DEXTROSE — Supplemental Application (Baxter Healthcare Corporation)
FDA approved a supplemental application for Dobutamine Hydrochloride in Dextrose, a Baxter product, indicating an approved change or additio…
-
CLINICAL_TRIALS trial_result · 2012-03-05Clinical Trial Update: Effects of Aliskiren, Ramipril, and the Combination on Levels of Angiotensin II in Patients With Decompensated Systolic Heart Failure [Phase 2]
This Phase 2 trial evaluated how aliskiren, ramipril, and their combination affect angiotensin II levels in patients with decompensated syst…
-
CLINICAL_TRIALS trial_result · 2012-03-02Clinical Trial Update: Total Body Albumin Measurement Utilizing a Modification of the BVA 100 Blood Volume Analyzer
This completed trial evaluated a modification of the BVA-100 blood volume analyzer for measuring total body albumin, sponsored by Daxor Corp…
-
CLINICAL_TRIALS trial_result · 2012-02-28Clinical Trial Update: Safety Comparison of Pioglitazone and Glyburide in Type 2 Diabetes Subjects With Mild to Moderate Congestive Heart Failure [Phase 3]
Phase 3 safety comparison trial comparing pioglitazone and glyburide in adults with type 2 diabetes mellitus and mild to moderate congestive…
-
CLINICAL_TRIALS trial_result · 2012-02-22Clinical Trial Update: The Effects of Glucocorticoids on Mortality and Renal Function in Patients With Acute Decompensated Heart Failure [Phase 2, Phase 3]
A clinical trial update on Phase 2/3 study evaluating glucocorticoids for mortality and renal outcomes in patients with acute decompensated …
-
FDA label_change · 2012-02-17FDA Approved: ENALAPRIL MALEATE — Supplemental Application (OCEANSIDE PHARMACEUTICALS)
The FDA approved a supplemental application for enalapril maleate (Oceanside Pharmaceuticals), resulting in a labeling update for the produc…
-
CLINICAL_TRIALS trial_result · 2012-02-09Clinical Trial Update: Safety and Efficacy of Low Dose Hypertonic Saline Solution and High Dose Furosemide for Congestive Heart Failure [Phase 3]
A Phase 3 clinical trial evaluating the safety and efficacy of low-dose hypertonic saline solution combined with high-dose furosemide for co…
-
CLINICAL_TRIALS trial_result · 2012-02-02Clinical Trial Update: Safety and Efficacy Study of Once and Twice Daily Doses of MCC-135 in Subjects With Congestive Heart Failure. [Phase 2]
Phase 2 safety and efficacy study of once- and twice-daily doses of MCC-135 in subjects with congestive heart failure has completed.
-
CLINICAL_TRIALS research · 2012-01-31Clinical Trial Update: Identification Of Blood Markers For Asymptomatic Ventricular Dysfunction
Clinical trial update focusing on identifying blood biomarkers for asymptomatic ventricular dysfunction.
-
CLINICAL_TRIALS trial_result · 2012-01-26Clinical Trial Update: Study of Left Ventricular Dyssynchrony in Heart Failure Patients
Completed clinical trial update examining left ventricular dyssynchrony in heart failure patients.